Grégory Saive

Grégory Saive currently serves as the VP of the Radiopharma business unit at Trasis since February 2025. Prior to this role, Grégory Saive spent nearly 17 years at IBA in various leadership positions, including Hadrontherapy Business Development Director, Sales Excellence Director, and Corporate Strategic Alliances Director, managing key partnerships with major companies in the industry. Grégory Saive's experience encompasses managing global teams, overseeing product management, and developing strategic business initiatives that significantly increased revenue and market share. Additional roles include Co-President at Normandy Hadrontherapy, Structure and Vibration Expert at Techspace Aero, and Teaching Assistant at the University of Liège. Grégory Saive holds an MBA from the Rotterdam School of Management and multiple degrees in physics and engineering from the University of Liège.